The US Food and Drug Administration has told manufacturers of prescription testosterone treatments for men that they need to add a warning on their drug label about an increased risk of blood clots in the veins.
Such clots can lead to complications such as deep vein thrombosis, which causes severe pain, or a life-threatening pulmonary embolism, which occurs when a clot breaks off and travels through the veins into the lungs.
